Open Label Trial to Compare BI 207127 to Telaprevir in HCV Patients

NCT01858961 · clinicaltrials.gov ↗

PHASE3

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Conditions

Hepatitis C, Chronic

Interventions

DRUG: BI 201335
DRUG: ribavirin
DRUG: BI 207127
DRUG: Telaprevir
DRUG: ribavirin
DRUG: Pegylated Interferon

Sponsor

Boehringer Ingelheim